ClinConnect ClinConnect Logo
Search / Trial NCT06754527

Options for Navigating Talking About Risk and Adolescent Choices

Launched by RHODE ISLAND HOSPITAL · Dec 30, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Adolescent Substance Use Emotion Regulation Risk Reduction

ClinConnect Summary

This clinical trial is studying an online program called ON-TRAC, which aims to help teenagers, aged 12 to 15, learn how to manage their emotions and reduce the risk of using drugs or alcohol. The study will involve 200 adolescents who will be randomly assigned to either take part in the ON-TRAC program or to be in a waitlist group, where they will receive the program later. Researchers want to see how this program affects participants' substance use, their ability to handle emotions, and their overall mental health.

To be eligible for this study, participants must have contact with the Rhode Island child welfare system and be dealing with issues related to abuse or neglect. They also need to be fluent in English and between 12 and 15 years old. Caregivers must be parents or guardians and can speak either English or Spanish, but they should not have developmental delays. Participants can expect to learn valuable skills through the program, and those in the waitlist group will have the opportunity to access the program after the study is complete.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Contact with the Rhode Island child welfare system
  • Caregiver who is a parent/guardian of a child who experienced maltreatment
  • Caregiver who speaks English or Spanish
  • Caregiver who does not have developmental delays
  • Adolescent who is between 12-15 years of age
  • Adolescent who is fluent in English
  • Adolescent who has active follow-up with the Rhode Island child welfare system due to an indicated finding of abuse or neglect in the past year
  • Exclusion Criteria:
  • Adolescent who cannot read at a 4th grade level
  • Adolescent who has a sibling who has participated in the program
  • Adolescent who has developmental delays
  • Adolescent who lacks parental consent for the study

About Rhode Island Hospital

Rhode Island Hospital, a leading academic medical center and a key component of the Lifespan health system, is committed to advancing medical research and improving patient care through innovative clinical trials. As a principal teaching hospital for The Warren Alpert Medical School of Brown University, it integrates cutting-edge research with high-quality clinical services. The hospital's extensive clinical trial program spans various fields, including oncology, cardiology, neurology, and more, aiming to enhance treatment options and patient outcomes. By fostering collaboration among researchers, clinicians, and patients, Rhode Island Hospital plays a pivotal role in translating scientific discoveries into effective therapies and improving healthcare delivery.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported